Institutional investors purchased a net $6.5 thousand shares of ZIOP during the quarter ended March 2014 and now own 35.35% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SMITH ASSET MANAGEMENT GROUP LP Bought 84.8 Thousand shares of ZIOPHARM Oncology Inc
FRANKLIN STREET ADVISORS, INC. Bought 4.6 Thousand shares of ZIOPHARM Oncology Inc